<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Vaccine Research</title>
<title_fa>Vaccine Research</title_fa>
<short_title>vacres</short_title>
<subject>Medical Sciences</subject>
<web_url>http://vacres.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-2819</journal_id_issn>
<journal_id_issn_online>2423-4923</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/vacres</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus</title>
	<subject_fa>Vaccine vectors, adjuvantsand immunomodulators</subject_fa>
	<subject>Vaccine vectors, adjuvantsand immunomodulators</subject>
	<content_type_fa>Original article</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;Avian influenza virus causes severe economic losses to the poultry industry and has a great potential for becoming a pandemic threat for humans. The application of natural adjuvants has opened up new avenues toward reaching a highly efficient and safe vaccine in recent years.&amp;nbsp; In this study, we investigated the adjuvant activity of interferon-induced myxovirus resistance (Mx) protein on chitosan-based H9N2 nanoparticles in a BALB/c mouse model. &lt;strong&gt;Methods:&lt;/strong&gt; The inactivated H9N2 virus antigen was encapsulated in chitosan nanoparticles (NPs) using gelation method. Female BALB/c mice were randomly divided into four groups (n=10). Group A received the H9N2-loaded chitosan NPs mixing with Mx intranasally and was boosted twice with a 1-week interval. Group B received the H9N2-loaded chitosan NPs in the same manner. Mice in groups C and D received the chitosan NPs and PBS, respectively as negative controls. Body weights of the mice were measured at defined times. Blood samples were collected from the animals and their influenza-specific antibody titer was determined using ELISA. &lt;strong&gt;Results:&lt;/strong&gt; The results demonstrated a higher antibody level in treated groups A and B as compared to the control samples. We also showed that the combination of Mx and chitosan could significantly induce an influenza-specific antibody titer, indicating synergistic effects of the applied adjuvant and NPs together. &lt;strong&gt;Conclusion:&lt;/strong&gt; The formulation of H9N2 with Mx as an adjuvant and chitosan as a nanocarrier is a promising procedure for developing an efficient vaccine against avian influenza virus.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Avian influenza, Chitosan, Mx, Nanoparticles, Immune responses</keyword>
	<start_page>34</start_page>
	<end_page>40</end_page>
	<web_url>http://vacres.pasteur.ac.ir/browse.php?a_code=A-10-1910-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Ahmadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m.ahmadi@rvsri.ac.ir</email>
	<code></code>
	<orcid>0000-0002-6121-6433</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gholamreza</first_name>
	<middle_name></middle_name>
	<last_name>Hashemi Tabar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hashemit@um.ac.ir</email>
	<code></code>
	<orcid>0000-0001-9760-1096</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahla</first_name>
	<middle_name></middle_name>
	<last_name>Shahsavandi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Shahsavandi26@gmail.com</email>
	<code></code>
	<orcid>0000-0002-9599-6722</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza </first_name>
	<middle_name></middle_name>
	<last_name>Haghparast</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
